Rights statement: http://journals.cambridge.org/action/displayJournal?jid=NEU The final, definitive version of this article has been published in the Journal, Acta Neuropsychiatrica, 28 (2), pp 110-116 2016, © 2016 Cambridge University Press.
Accepted author manuscript, 274 KB, PDF document
Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License
Final published version
Research output: Contribution to Journal/Magazine › Journal article › peer-review
| <mark>Journal publication date</mark> | 04/2016 |
|---|---|
| <mark>Journal</mark> | Acta Neuropsychiatrica |
| Issue number | 2 |
| Volume | 28 |
| Number of pages | 7 |
| Pages (from-to) | 110-116 |
| Publication Status | Published |
| Early online date | 15/10/15 |
| <mark>Original language</mark> | English |
OBJECTIVE: The brainstem-derived neuropeptide S (NPS) has a multidirectional regulatory activity, especially as a potent anxiolytic factor. Accumulating data suggests that neuroleptics affect peptidergic signalling in various brain structures. However, there is no information regarding the influence of haloperidol on NPS and NPS receptor (NPSR) expression.
METHODS: We assessed NPS and NPSR mRNA levels in brains of rats treated with haloperidol using quantitative real-time polymerase chain reaction.
RESULTS: Chronic haloperidol treatment (4 weeks) led to a striking upregulation of NPS and NPSR expression in the rat brainstem. Conversely, the NPSR mRNA expression was decreased in the hippocampus and striatum.
CONCLUSIONS: This stark increase of NPS in response to haloperidol treatment supports the hypothesis that this neuropeptide is involved in the dopamine-dependent anxiolytic actions of neuroleptics and possibly also in the pathophysiology of mental disorders. Furthermore, our findings underline the complex nature of potential interactions between dopamine receptors and brain peptidergic pathways, which has potential clinical applications.